These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


386 related items for PubMed ID: 17184924

  • 1. Role of glutathione in neuroprotective effects of mood stabilizing drugs lithium and valproate.
    Cui J, Shao L, Young LT, Wang JF.
    Neuroscience; 2007 Feb 23; 144(4):1447-53. PubMed ID: 17184924
    [Abstract] [Full Text] [Related]

  • 2. The effect of mood stabilizer lithium on expression and activity of glutathione s-transferase isoenzymes.
    Shao L, Cui J, Young LT, Wang JF.
    Neuroscience; 2008 Jan 24; 151(2):518-24. PubMed ID: 18082333
    [Abstract] [Full Text] [Related]

  • 3. Chronic treatment with mood stabilizers lithium and valproate prevents excitotoxicity by inhibiting oxidative stress in rat cerebral cortical cells.
    Shao L, Young LT, Wang JF.
    Biol Psychiatry; 2005 Dec 01; 58(11):879-84. PubMed ID: 16005436
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Mood stabilizers commonly restore staurosporine-induced increase of p53 expression and following decrease of Bcl-2 expression in SH-SY5Y cells.
    Song N, Boku S, Nakagawa S, Kato A, Toda H, Takamura N, Omiya Y, Kitaichi Y, Inoue T, Koyama T.
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Aug 07; 38(2):183-9. PubMed ID: 22484386
    [Abstract] [Full Text] [Related]

  • 6. Glutathione S-transferase is a novel target for mood stabilizing drugs in primary cultured neurons.
    Wang JF, Shao L, Sun X, Young LT.
    J Neurochem; 2004 Mar 07; 88(6):1477-84. PubMed ID: 15009649
    [Abstract] [Full Text] [Related]

  • 7. Co-culture of neurones with glutathione deficient astrocytes leads to increased neuronal susceptibility to nitric oxide and increased glutamate-cysteine ligase activity.
    Gegg ME, Clark JB, Heales SJ.
    Brain Res; 2005 Mar 02; 1036(1-2):1-6. PubMed ID: 15725395
    [Abstract] [Full Text] [Related]

  • 8. Myristoylated alanine-rich C kinase substrate (MARCKS): a molecular target for the therapeutic action of mood stabilizers in the brain?
    Lenox RH, McNamara RK, Watterson JM, Watson DG.
    J Clin Psychiatry; 1996 Mar 02; 57 Suppl 13():23-31; discussion 32-3. PubMed ID: 8970502
    [Abstract] [Full Text] [Related]

  • 9. The antiapoptotic actions of mood stabilizers: molecular mechanisms and therapeutic potentials.
    Chuang DM.
    Ann N Y Acad Sci; 2005 Aug 02; 1053():195-204. PubMed ID: 16179524
    [Abstract] [Full Text] [Related]

  • 10. Mood stabilizing drugs lamotrigine and olanzapine increase expression and activity of glutathione S-transferase in primary cultured rat cerebral cortical cells.
    Bakare A, Shao L, Cui J, Young LT, Wang JF.
    Neurosci Lett; 2009 May 08; 455(1):70-3. PubMed ID: 19429109
    [Abstract] [Full Text] [Related]

  • 11. Neuroprotective effect of epigallocatechin-3-gallate against beta-amyloid-induced oxidative and nitrosative cell death via augmentation of antioxidant defense capacity.
    Kim CY, Lee C, Park GH, Jang JH.
    Arch Pharm Res; 2009 Jun 08; 32(6):869-81. PubMed ID: 19557365
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Comparative analysis of the effects of four mood stabilizers in SH-SY5Y cells and in primary neurons.
    Di Daniel E, Mudge AW, Maycox PR.
    Bipolar Disord; 2005 Feb 08; 7(1):33-41. PubMed ID: 15654930
    [Abstract] [Full Text] [Related]

  • 14. The common inositol-reversible effect of mood stabilizers on neurons does not involve GSK3 inhibition, myo-inositol-1-phosphate synthase or the sodium-dependent myo-inositol transporters.
    Di Daniel E, Cheng L, Maycox PR, Mudge AW.
    Mol Cell Neurosci; 2006 Feb 08; 32(1-2):27-36. PubMed ID: 16531065
    [Abstract] [Full Text] [Related]

  • 15. Valproate and neuroprotective effects for bipolar disorder.
    Atmaca M.
    Int Rev Psychiatry; 2009 Feb 08; 21(4):410-3. PubMed ID: 20374154
    [Abstract] [Full Text] [Related]

  • 16. Neuroprotection of Ilex latifolia and caffeoylquinic acid derivatives against excitotoxic and hypoxic damage of cultured rat cortical neurons.
    Kim JY, Lee HK, Hwang BY, Kim S, Yoo JK, Seong YH.
    Arch Pharm Res; 2012 Jun 08; 35(6):1115-22. PubMed ID: 22870822
    [Abstract] [Full Text] [Related]

  • 17. Unlike lithium, anticonvulsants and antidepressants do not alter rat brain myo-inositol.
    McGrath BM, Greenshaw AJ, McKay R, Slupsky CM, Silverstone PH.
    Neuroreport; 2007 Oct 08; 18(15):1595-8. PubMed ID: 17885608
    [Abstract] [Full Text] [Related]

  • 18. Valproate inhibits oxidative damage to lipid and protein in primary cultured rat cerebrocortical cells.
    Wang JF, Azzam JE, Young LT.
    Neuroscience; 2003 Oct 08; 116(2):485-9. PubMed ID: 12559103
    [Abstract] [Full Text] [Related]

  • 19. Differential display PCR reveals novel targets for the mood-stabilizing drug valproate including the molecular chaperone GRP78.
    Wang JF, Bown C, Young LT.
    Mol Pharmacol; 1999 Mar 08; 55(3):521-7. PubMed ID: 10051536
    [Abstract] [Full Text] [Related]

  • 20. Galantamine protects against oxidative stress induced by amyloid-beta peptide in cortical neurons.
    Melo JB, Sousa C, Garção P, Oliveira CR, Agostinho P.
    Eur J Neurosci; 2009 Feb 08; 29(3):455-64. PubMed ID: 19222556
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 20.